Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/09/2010US20100311088 Recombinant antigens for diagnosis and prevention of murine typhus
12/09/2010US20100311075 Human sodium-dependent bile acid transporter proteins
12/09/2010US20100311045 Cancer
12/09/2010US20100310710 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
12/09/2010US20100310688 acacia extracts and their compounds on inhibition of xanthine oxidase
12/09/2010US20100310687 Anti-gastritis and anti-ulcer agent containing momordicae semen extract and momordica saponin i isolated from the same
12/09/2010US20100310684 Methods for treating and preventing mucositis
12/09/2010US20100310683 Pharmaceutical compositions for treating depression and anxiety
12/09/2010US20100310682 Pharmaceutical compositions for treating anxiety
12/09/2010US20100310681 Modulation of KCNQ Potassium Channel Activity for Treatment of Psychiatric Disorders and the Symptoms Thereof
12/09/2010US20100310680 Composition and method for treating acne
12/09/2010US20100310675 Aminopyrimidines useful as kinase inhibitors
12/09/2010US20100310674 Novel composition for treating the side effects of anticancer treatments
12/09/2010US20100310671 Encapsulated low viscosity hydrophobic liquid actives
12/09/2010US20100310670 Sustained-release microsphere containing short chain deoxyribonucleic acid or short chain ribonucleic acid and method of producing the same
12/09/2010US20100310668 Pharmaceutical compositions comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide
12/09/2010US20100310666 Delivery of Functional Compounds
12/09/2010US20100310665 Bacteriostatic or bacteriocidal compositions and methods
12/09/2010US20100310664 Compositions and methods for treating insulin resistance and diabetes mellitus
12/09/2010US20100310663 Pharmaceutical compositions comprising nanoparticles and a resuspending material
12/09/2010US20100310662 Oral Drug Delivery System for Azole, Moxifloxacin and Rifampicin
12/09/2010US20100310661 Oral formulations for picoplatin
12/09/2010US20100310660 Dry powder microparticles for pulmonary delivery
12/09/2010US20100310659 Compositions and Uses Thereof
12/09/2010US20100310657 Pharmaceutical composition for treatment and prevention of kidney diseases
12/09/2010US20100310655 Crystal modification A of 1-(2,6-difluorobenzyl)-1 H-1,2,3-triazole-4-carboxamide and dosage forms and formulations thereof
12/09/2010US20100310652 Coated extended release pharmaceutical compositions of levetiracetam
12/09/2010US20100310651 Solid pharmaceutical compositions and processes for their production
12/09/2010US20100310650 Pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation
12/09/2010US20100310648 Pharmaceutical dosage form for oral administration of a bcl 2 family inhibitor
12/09/2010US20100310647 Enzymatic Synthesis of Polymers
12/09/2010US20100310645 Methods for inhibiting tumor cell proliferation
12/09/2010US20100310642 Topical Drug Delivery Systems for Ophthalmic Use
12/09/2010US20100310641 Therapeutic approaches for treating cmt and related disorders
12/09/2010US20100310638 Liposomes comprising duramycin and anti-viral agents
12/09/2010US20100310635 Compositions and Methods for Regulating T-Cell Activity
12/09/2010US20100310629 Intrapericardial antiarrhythmic delivery
12/09/2010US20100310622 Dry eye treatment by puncta plugs
12/09/2010US20100310613 Drug delivery system
12/09/2010US20100310611 Parenteral and oral formulations of benzimidazoles
12/09/2010US20100310610 Compositions and methods for controlling drug loss and delivery in transdermal drug delivery systems
12/09/2010US20100310609 Compositions and methods for treatment of neurodegenerative diseases
12/09/2010US20100310608 Sequestering subunit and related compositions and methods
12/09/2010US20100310607 Pharmaceutical formulations
12/09/2010US20100310602 Synthetic glucopyranosyl lipid adjuvants
12/09/2010US20100310600 Selective agonist of toll-like receptor 3
12/09/2010US20100310599 Orally Bioavailable Lipid-Based Constructs
12/09/2010US20100310595 Method of transfection and compositions therefor
12/09/2010US20100310583 Let-7 microrna and mimetics thereof as therapeutics for cancer
12/09/2010US20100310580 Compositions and methods for treating pruritus
12/09/2010US20100310579 Method for inhibiting angiogenesis or for treatment of cancer
12/09/2010US20100310578 Use of lipocalin-2 as a diagnostic marker and therapeutic target
12/09/2010US20100310577 Methods for increasing thermogenic adipocytes
12/09/2010US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES
12/09/2010US20100310575 Inhibitors of Caspase I-Dependent Cytokines in the Treatment of Neurodegenerative Disorders
12/09/2010US20100310574 Methods and compositions for the treatment and diagnosis of statin-induced myopathy
12/09/2010US20100310569 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae
12/09/2010US20100310564 Method for the Treatment of Glomerulonephritis
12/09/2010US20100310563 Methods for treating induced cellular proliferative disorders
12/09/2010US20100310560 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
12/09/2010US20100310555 Compositions with hematopoietic and immune activity
12/09/2010US20100310553 Compositions and Methods for Controlling Hepatitis C Virus Infection
12/09/2010US20100310547 Treatment of Inflammatory Diseases
12/09/2010US20100310543 Method of preventing and treating acute brain pathologies
12/09/2010US20100310542 Pharmaceutical Compositions for treating wouds and related methods
12/09/2010US20100310541 Compositions and Methods for Reducing the Toxicity of Certain Toxins
12/09/2010US20100310540 Methods of screening for compounds that modulate tafia activity, compounds, and methods of using the compounds
12/09/2010US20100310539 Method for manufacturing mesoporous materials, materials so produced and use of mesoporous materials
12/09/2010US20100310538 Use of r(+)-alpha-lipoic acid for cryptogenic neuropathy
12/09/2010US20100310532 Gene targets in anti-aging therapy and tissue repair
12/09/2010US20100310522 Novel Polypeptides Having Endolysin Activity and Uses Thereof
12/09/2010US20100310521 Polynucleotide sequence for the inhibition of phospholamban synthesis
12/09/2010US20100310516 Duplexed Parvovirus Vectors
12/09/2010US20100310515 Latency Associated Protein Construct With Aggrecanase Sensitive Cleavage Site
12/09/2010US20100310512 Antiviral compounds
12/09/2010US20100310510 N-terminally chemically modified protein compositions and methods
12/09/2010US20100310508 METHODS OF TREATMENT INVOLVING p21/CIP1
12/09/2010US20100310506 Immunoconjugates for the Treatment of Tumours
12/09/2010US20100310504 Methods for treating fibrosis by modulating cellular senescence
12/09/2010US20100310503 Novel compositions and methods for cancer treatment
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010US20100310498 Active agents and their oligomers and polymers
12/09/2010US20100310497 Pharmaceutical composition or combination drug
12/09/2010US20100310496 Method of producing amino acid-modified organopolysiloxane emulsions
12/09/2010US20100310494 Styrax Benzoin Rejuvenating Cosmetic Preparation
12/09/2010US20100310493 Acetamide derivatives as glucokinase activators, their process and medicinal application
12/09/2010US20100310487 Active ingredient combination and use thereof
12/09/2010US20100310483 Compositions Comprising Phosphoric Acid Ester And Hydrophobically Modified, Crosslinked Anionic Polymers
12/09/2010US20100310482 3-Deoxyglucosone And Skin
12/09/2010US20100310480 Dapsone to treat rosascea
12/09/2010US20100310477 Pharmaceutical compositions based on anticholingerics and additional active ingredients
12/09/2010US20100310474 Protein cages for the delivery of medical imaging and therapeutic agents
12/09/2010US20100310473 Targeting Brain Cells Via Ophthalmic Delivery
12/09/2010US20100310471 Antioxidant and paramagnetic heparin-nitroxide derivatives
12/09/2010US20100310470 Immunomodulatory polymeric antigens for treating inflammatory pathologies
12/09/2010US20100310469 Vaccine immunotherapy for immune suppressed patients
12/09/2010US20100310466 Thienopyranones as kinase inhibitors
12/09/2010US20100310465 Nano-devices having releasable seals for controlled release of molecules
12/09/2010US20100310462 Binding of pathological forms of proteins using conjugated polyelectrolytes
12/09/2010US20100310461 Binding of pathological forms of proteins using conjugated polyelectrolytes
1 ... 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 ... 7860